Skip to main content

Table 3 Demonstration of the model-estimated survival probability at each time point from nine sample patients

From: Natural disease progression and novel survival prediction model for hepatocellular carcinoma with spinal metastases: a 10-year single-center study

Input predictor variablesModel estimation of survival probability (%, 95% confidence interval)
NoAgeKPSTotal bilirubinNumber of primary tumor3 months6 months12 months
141Good0.8Single89.5 (74.9–95.9)83.4 (62.1–93.3)69.4 (43.1–85.4)
264Good1.2Single82.2 (56.2–93.6)72.5 (38.9–89.6)52.4 (17.8–78.5)
352Good1.8Multiple74.8 (57.6–85.8)62.0 (41.2–77.3)38.3 (19.4–57.1)
466Moderate1.6Single67.6 (41.0–84.2)52.5 (23.3–75.2)27.5 (6.5–54.4)
556Moderate2.3Single61.2 (21.0–85.7)44.6 (7.1–78.2)19.8 (0.6–60.0)
646Good3.2Single31.5 (1.2–73.8)15.0 (0.1–62.2)2.2 (0–35.9)
748Good3.4Multiple4.8 (0–35.7)0.7 (0–19.9)0 (0–3.6)
869Poor3.8Single0.2 (0–17.7)0 (0–6.6)0 (0–0.4)
976Poor6.9Multiple0 (0–0.4)0 (0)0 (0)
  1. Abbreviation: KPS Karnofsky Performance Status